Can Quitting Weed Cause Depression?

Depressed mood is a recognized symptom of cannabis withdrawal, reported by roughly six in ten people who develop the full withdrawal syndrome after stopping heavy use. It is listed as a diagnostic criterion in psychiatric classification systems and has well-studied neurobiological underpinnings. But the relationship between quitting weed and feeling depressed is not as straightforward as that statistic suggests, because the depression can stem from withdrawal itself, from an underlying mood disorder that cannabis was masking, or from both at once.

How Common Is Depressed Mood After Quitting

Not everyone who stops using cannabis experiences withdrawal, and not everyone who experiences withdrawal gets depressed. In a large nationally representative survey of frequent cannabis users in the United States, about 12% met criteria for a formal cannabis withdrawal syndrome. Among that group, depressed mood was the fourth most common symptom, reported by about 59% of those affected. The three symptoms reported more often were nervousness or anxiety, hostility, and trouble sleeping.¹

Those numbers mean that for the broader population of people who use cannabis regularly and then stop, the chance of clinically meaningful depressed mood during withdrawal is fairly low. It tends to cluster among people who use heavily, use daily or near-daily, and have been using for years. Occasional or moderate users who take a break are unlikely to experience anything beyond mild irritability or sleep disruption.

The Timeline of Withdrawal Depression

Cannabis withdrawal follows a distinct arc, and depressed mood does not follow the same schedule as other symptoms. Most withdrawal symptoms begin within 24 to 48 hours after the last use and peak somewhere between days two and six. But depressed mood is a late bloomer. It can appear as early as the first week, yet it typically does not peak until around two weeks into abstinence.² That delayed peak catches people off guard. Someone might feel reasonably fine for the first several days, start to think they are in the clear, and then get blindsided by a low mood that seems to come from nowhere.

For most people, withdrawal symptoms begin to fade within two to three weeks of stopping.³ Heavy, long-term users sometimes experience symptoms that linger longer, and sleep disturbances can outlast everything else. Still, the core message is that the depressed feeling has a beginning, a middle, and an end. It is not permanent, even though it can feel that way during the worst of it.

What Is Happening in the Brain

THC, the primary psychoactive compound in cannabis, works by binding to cannabinoid receptors (CB1 receptors) throughout the brain. When you use cannabis regularly, the brain adapts by reducing the number and sensitivity of those receptors. Brain imaging studies show that daily cannabis users have roughly 15% lower CB1 receptor availability compared to non-users.⁴ When you stop using, the external THC disappears but the receptors are still in their diminished state, and it takes time for them to bounce back. During that gap, the brain’s natural mood-regulating systems are running below capacity.

The good news is that recovery happens relatively quickly. One imaging study found that group-level differences in CB1 receptor availability between cannabis users and non-users were no longer detectable after just two days of abstinence, though individual variation was significant. By 28 days, receptor availability had fully normalized.⁴ A separate study using a different imaging technique confirmed that after about 30 days of supervised abstinence, daily cannabis users had CB1 receptor levels comparable to healthy controls, and that the degree of initial downregulation correlated with years of use.³

There is also a dopamine angle. Animal research has shown that chronic THC exposure changes how dopamine receptors interact in the brain’s reward circuitry. Specifically, repeated THC use increases the formation of a particular dopamine receptor complex that, through a cascade involving the brain’s internal opioid system, ends up reducing dopamine release. Lower dopamine activity in the reward system is strongly linked to anhedonia, which is the inability to feel pleasure, one of the hallmarks of depression.⁵ So during withdrawal, you are dealing with a double hit: an endocannabinoid system that is temporarily weakened and a reward system that is producing less dopamine than it should.

Withdrawal Depression Versus an Underlying Mood Disorder

One of the trickiest aspects of post-cessation depression is figuring out where the withdrawal ends and where a pre-existing or independent mood disorder begins. Some people use cannabis heavily precisely because they are self-medicating an undiagnosed depression, anxiety disorder, or other psychiatric condition. When the cannabis goes away, the thing it was covering up becomes visible again. This is sometimes called “unmasking.”

Research on this distinction has found that cannabis dependence is strongly associated with what clinicians call independent depression, meaning a depressive disorder that exists on its own and was not caused by the substance use. In a study comparing depression types across different drug dependencies, cannabis dependence was a highly significant predictor of independent major depression, while cocaine dependence was more associated with substance-induced depression.⁶ That finding matters practically: if your low mood after quitting is actually an independent depression that cannabis was suppressing, it will not resolve on the same timeline as withdrawal. It needs its own treatment.

There is no easy way to tell the difference in real time. The most useful rule of thumb is duration. If the depressed mood is part of withdrawal, it should start improving within two to four weeks. If it persists at the same intensity well past the one-month mark, that is a strong signal that something more than withdrawal is going on, and professional evaluation is worth pursuing. Stress reactivity during early abstinence can also complicate the picture. Cannabis users going through withdrawal show heightened cortisol and stress-hormone responses to everyday stressors, which can amplify low mood even when the underlying biology is recovering on schedule.⁷

Who Tends to Have a Harder Time

Several factors influence how severe withdrawal depression is likely to be.

People with a history of psychiatric illness tend to experience a delayed recovery. In a study of young adults going through monitored cannabis abstinence, those with a lifetime psychiatric diagnosis did not begin to see improvement in withdrawal symptom severity until their second week of abstinence, about a week later than participants without a psychiatric history.⁸ The symptoms did eventually improve for both groups over the four-week observation period, but that extra week of suffering is meaningful. It represents a window in which people are more vulnerable to relapse.

Sex also plays a role. Women consistently report more intense withdrawal symptoms than men, both in total number and in severity. In one study of treatment-seeking cannabis users, women had significantly higher overall withdrawal scores than men and reported more symptoms on average. The difference was most pronounced for mood symptoms like irritability, anger, and restlessness, as well as gastrointestinal symptoms.⁹ A separate study looking at endocannabinoid levels during abstinence found that women showed a substantially larger spike in withdrawal symptoms during the first abstinent week compared to men, whose symptoms barely changed from baseline.¹⁰ The biological reasons for this are still being worked out, but differences in how men and women metabolize cannabinoids and in baseline endocannabinoid tone are likely contributors.

Potency and pattern of use matter as well. Higher-THC products and more frequent consumption are associated with more pronounced withdrawal across the board. The duration and severity of cannabis withdrawal tracks with the amount consumed before cessation.² With cannabis concentrates and high-potency flower becoming more common, the risk of difficult withdrawal may be increasing for the population as a whole.

Does the Depression Improve With Longer Abstinence

The evidence on longer-term outcomes is encouraging. A study of people with both major depressive disorder and cannabis use disorder found that extended abstinence was associated with a roughly 44% reduction in depressive symptoms and a striking 89% reduction in anhedonia specifically.¹¹ That anhedonia finding is particularly interesting given the dopamine-related mechanism described earlier. As the brain’s reward circuitry normalizes, the ability to experience pleasure from everyday activities returns, and for many people it returns dramatically.

A larger study that tracked cannabis users over time found that people who significantly reduced their use showed meaningful improvements in depression, anxiety, and sleep quality compared to those who maintained the same level of use. The improvements in depression were statistically robust even after controlling for other substance use and demographic factors.¹² One notable finding from this study was that quality of life did not improve alongside the other measures, which the authors interpreted as reflecting the broader life disruptions that heavy cannabis use can cause, things that take longer to rebuild than brain chemistry.

Adolescent and young adult users also see improvement. In a monitored abstinence study of adolescent cannabis users, subsyndromal depression, sleep quality, and positive expectations about marijuana all improved over a 28-day period.¹³ The convergence of these findings across different populations suggests that while the first few weeks are rough, the trajectory tilts firmly toward feeling better over time.

What Helps During the Withdrawal Period

There is no medication approved anywhere in the world specifically for cannabis withdrawal. Researchers have tested antidepressants, mood stabilizers, anti-anxiety drugs, and medications used for other substance dependencies, with mostly disappointing results.¹⁴ Escitalopram, a commonly prescribed SSRI antidepressant, was tested in a double-blind trial and showed no advantage over placebo for either cannabis abstinence rates or depression and anxiety scores during withdrawal.¹⁵ Small studies have suggested some limited antidepressants can actually worsen withdrawal symptoms, and venlafaxine in particular has been flagged as potentially counterproductive.¹⁶

Nabiximols, a pharmaceutical cannabis extract that contains both THC and CBD, showed a modest signal for reducing depression during withdrawal in one randomized trial, though results were mixed across other symptom domains.¹⁷ The idea behind it is agonist replacement, similar in concept to how nicotine patches work for tobacco cessation: give the receptor system a lower, controlled dose of what it expects while it readjusts, rather than cutting everything off at once. This approach remains experimental.

Exercise is one of the more promising non-pharmacological strategies, and the mechanism makes intuitive sense. Aerobic exercise stimulates the body’s own endocannabinoid production, raising levels of natural molecules that bind to the same receptors THC targets. These endocannabinoids, including anandamide, are involved in mood regulation, pain relief, and stress buffering. Exercise-induced increases in endocannabinoid levels also appear to raise levels of brain-derived neurotrophic factor (BDNF), a protein associated with improved mood and neural repair. The overall effect could help partially bridge the gap that opens when external THC is removed.³ Formal clinical trial evidence specifically for exercise during cannabis withdrawal is still limited, but the biological rationale is solid and the risk is essentially zero.

Beyond these specific interventions, the overall framework for managing withdrawal depression is managing withdrawal itself: maintaining good sleep hygiene, staying socially connected, keeping a routine, and knowing that the timeline is finite. Cognitive behavioral therapy adapted for cannabis use has consistent evidence supporting its effectiveness and is considered a first-line approach. The most important practical knowledge may simply be that the worst of it, including the depressed mood, has a predictable end point, and that for most people that end point falls within the first month.

Adolescent Exposure and Lasting Mood Effects

Most research on cannabis withdrawal depression focuses on what happens acutely after quitting, but there is a separate question about whether heavy cannabis use during adolescence can leave lasting imprints on the brain’s mood circuitry that persist beyond the typical withdrawal window. Animal research has found that adolescent THC exposure can produce long-lasting depressive-like behaviors, reduced cell growth in the hippocampus, and smaller hippocampal volume. Researchers have attributed this to a sustained decrease in CB1 receptor function in specific brain regions. In one experiment, treating THC-exposed adult female rats with a drug that boosts the brain’s natural endocannabinoid signaling reversed most of the depressive-like symptoms, including anhedonia and passive coping behavior.¹⁸

Translating rat studies to humans always requires caution, but the finding points to something worth knowing: for people who started using cannabis heavily as teenagers and are now quitting as adults, the mood disruption they experience may not fall neatly into either the “withdrawal” or the “unmasked pre-existing depression” box. It could involve lasting neuroplastic changes from adolescent exposure that are distinct from both categories. This is an area where the science is still early, and where the practical advice is the same regardless of the mechanism: if depressed mood persists well beyond the expected withdrawal timeline, seek professional help rather than assuming it will resolve on its own or that going back to cannabis is the only fix.

1
PubMed Central. DSM-5 Cannabis Withdrawal Syndrome: Demographic and clinical correlates in U.S. adults
2
PubMed Central. Clinical management of cannabis withdrawal
3
PubMed Central. Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences
4
PubMed Central. Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis
5
PubMed Central. Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism
6
PubMed Central. A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers
7
PubMed Central. Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals
8
PubMed Central. Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness
9
PubMed Central. Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users
10
PubMed Central. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence
11
Canadian Journal of Addiction. Effects of Extended Cannabis Abstinence in Major Depressive Disorder
12
PubMed Central. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life
13
PubMed Central. Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users
14
PubMed Central. Pharmacological treatment of cannabis dependence
15
PubMed. Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study
16
PubMed Central. The cannabis withdrawal syndrome: current insights
17
JAMA Psychiatry. Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial
18
PubMed Central. Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats